167 related articles for article (PubMed ID: 30235476)
1. Platelet Reactivity and Early Outcomes after Transfemoral Aortic Valve Implantation.
Gross L; Jochheim D; Nitschke T; Baquet M; Orban M; Holdt L; Zadrozny M; Hagl C; Teupser D; Bauer A; Massberg S; Mehilli J; Sibbing D
Thromb Haemost; 2018 Oct; 118(10):1832-1838. PubMed ID: 30235476
[TBL] [Abstract][Full Text] [Related]
2. The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation.
Czerwińska-Jelonkiewicz K; Witkowski A; Dąbrowski M; Piotrowski W; Hryniewiecki T; Stępińska J
Arch Cardiovasc Dis; 2018 Apr; 111(4):233-245. PubMed ID: 29126843
[TBL] [Abstract][Full Text] [Related]
3. Platelet reactivity in patients undergoing transcatheter aortic valve implantation.
Orvin K; Eisen A; Perl L; Zemer-Wassercug N; Codner P; Assali A; Vaknin-Assa H; Lev EI; Kornowski R
J Thromb Thrombolysis; 2016 Jul; 42(1):11-8. PubMed ID: 26695072
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial.
Jimenez Diaz VA; Tello-Montoliu A; Moreno R; Cruz Gonzalez I; Baz Alonso JA; Romaguera R; Molina Navarro E; Juan Salvadores P; Paredes Galan E; De Miguel Castro A; Bastos Fernandez G; Ortiz Saez A; Fernandez Barbeira S; Raposeiras Roubin S; Ocampo Miguez J; Serra Peñaranda A; Valdes Chavarri M; Cequier Fillat A; Calvo Iglesias F; Iñiguez Romo A
JACC Cardiovasc Interv; 2019 Jan; 12(1):22-32. PubMed ID: 30621974
[TBL] [Abstract][Full Text] [Related]
5. Baseline platelet indices and bleeding after transcatheter aortic valve implantation.
Huczek Z; Kochman J; Kowara MK; Wilimski R; Scislo P; Scibisz A; Rymuza B; Andrzejewska R; Stanecka P; Filipiak KJ; Opolski G
Blood Coagul Fibrinolysis; 2015 Jul; 26(5):527-32. PubMed ID: 25811449
[TBL] [Abstract][Full Text] [Related]
6. Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation.
El-Mawardy M; Schwarz B; Landt M; Sulimov D; Kebernik J; Allali A; Becker B; Toelg R; Richardt G; Abdel-Wahab M
EuroIntervention; 2017 Jan; 12(13):1667-1673. PubMed ID: 28106001
[TBL] [Abstract][Full Text] [Related]
7. Impact of Comorbidities and Antiplatelet Regimen on Platelet Reactivity Levels in Patients Undergoing Transcatheter Aortic Valve Implantation.
Trejo-Velasco B; Tello-Montoliu A; Cruz-González I; Moreno R; Baz-Alonso JA; Salvadores PJ; Romaguera R; Molina-Navarro E; Paredes-Galán E; Fernández-Barbeira S; Ortiz-Saez A; Bastos-Fernandez G; De Miguel-Castro A; Figueiras-Guzman A; Iñiguez-Romo A; Jimenez-Diaz VA
J Cardiovasc Pharmacol; 2021 Sep; 78(3):463-473. PubMed ID: 34117181
[TBL] [Abstract][Full Text] [Related]
8. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
[TBL] [Abstract][Full Text] [Related]
9. Pre-procedural dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation increases risk of bleeding.
Hioki H; Watanabe Y; Kozuma K; Nara Y; Kawashima H; Kataoka A; Yamamoto M; Takagi K; Araki M; Tada N; Shirai S; Yamanaka F; Hayashida K;
Heart; 2017 Mar; 103(5):361-367. PubMed ID: 27540180
[TBL] [Abstract][Full Text] [Related]
10. High on-treatment platelet reactivity in transcatheter aortic valve implantation patients.
Polzin A; Schleicher M; Seidel H; Scharf RE; Merx MW; Kelm M; Zeus T
Eur J Pharmacol; 2015 Mar; 751():24-7. PubMed ID: 25641745
[TBL] [Abstract][Full Text] [Related]
11. Pre-procedural dual antiplatelet therapy and bleeding events following transcatheter aortic valve implantation (TAVI).
Huczek Z; Kochman J; Grygier M; Parma R; Scislo P; Wilimski R; Ochala A; Lesiak M; Olasinska-Wisniewska A; Grabowski M; Mazurek T; Sibbing D; Filipiak KJ; Opolski G
Thromb Res; 2015 Jul; 136(1):112-7. PubMed ID: 26004748
[TBL] [Abstract][Full Text] [Related]
12. Meta-Analysis Comparing Single Versus Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation.
Maes F; Stabile E; Ussia GP; Tamburino C; Pucciarelli A; Masson JB; Marsal JR; Barbanti M; Côté M; Rodés-Cabau J
Am J Cardiol; 2018 Jul; 122(2):310-315. PubMed ID: 29861051
[TBL] [Abstract][Full Text] [Related]
13. Meta-Analysis Comparing the Safety and Efficacy of Single vs Dual Antiplatelet Therapy in Post Transcatheter Aortic Valve Implantation Patients.
Ullah W; Zghouzi M; Ahmad B; Biswas S; Zaher N; Sattar Y; Pacha HM; Goldsweig AM; Velagapudi P; Fichman DL; Prasad A; Alraies MC
Am J Cardiol; 2021 Apr; 145():111-118. PubMed ID: 33454348
[TBL] [Abstract][Full Text] [Related]
14. Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantation.
Amabile N; Azmoun A; Ghostine S; Ramadan R; Haddouche Y; Raoux F; To NT; Troussier X; Nottin R; Caussin C
Int J Cardiol; 2013 Sep; 168(1):151-6. PubMed ID: 23079085
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
[TBL] [Abstract][Full Text] [Related]
16. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
[TBL] [Abstract][Full Text] [Related]
17. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
[TBL] [Abstract][Full Text] [Related]
18. Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry - POL-TAVI.
Czerwińska-Jelonkiewicz K; Zembala M; Dąbrowski M; Witkowski A; Ochała A; Kochman J; Dudek D; Kübler P; Jagielak D; Stępińska J
Int J Cardiol; 2017 Jan; 227():305-311. PubMed ID: 27843052
[TBL] [Abstract][Full Text] [Related]
19. Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions.
Steinvil A; Leshem-Rubinow E; Halkin A; Abramowitz Y; Ben-Assa E; Shacham Y; Bar-Dayan A; Keren G; Banai S; Finkelstein A
Am J Cardiol; 2015 Jan; 115(1):100-6. PubMed ID: 25456874
[TBL] [Abstract][Full Text] [Related]
20. Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation.
Mangieri A; Jabbour RJ; Montalto C; Pagnesi M; Regazzoli D; Ancona MB; Giannini F; Tanaka A; Bertoldi L; Monaco F; Agricola E; Giglio M; Mattioli R; Ferri L; Montorfano M; Chieffo A; Alfieri O; Colombo A; Latib A
Am J Cardiol; 2017 Apr; 119(7):1088-1093. PubMed ID: 28237287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
